First Manhattan’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

First Manhattan’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-231,800	Closed	-$771K	–	1509
2019 Q4	$771K	Sell	231,800 -177,700	-43%	-$565K	﹤0.01%	456
2019 Q3	$1.24M	Sell	409,500 -22,700	-5%	-$63.8K	0.01%	381
2019 Q2	$1.03M	Sell	432,200 -40,100	-8%	-$120K	0.01%	427
2019 Q1	$1.77M	Sell	472,300 -38,200	-7%	-$143K	0.01%	356
2018 Q4	$1.83M	Sell	510,500 -107,000	-17%	-$465K	0.01%	350
2018 Q3	$3.54M	Buy	617,500 +582,500	+1,664%	+$3.33M	0.02%	302
2018 Q2	$175K	Buy	35,000 +2,500	+8%	+$12.9K	﹤0.01%	721
2018 Q1	$166K	Buy	32,500 +1,000	+3%	+$6.02K	﹤0.01%	708
2017 Q4	$189K	Buy	31,500 +20,000	+174%	+$120K	﹤0.01%	722
2017 Q3	$63K	Buy	+11,500	New	+$59.4K	﹤0.01%	908

First Manhattan's FOMX Position: Q1 2020 in Review

First Manhattan sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 231,800 shares — an estimated $771K sold.

First Manhattan first reported a position in FOMX in Q3 2017 and held it in 10 quarters. The position peaked at $3.54M in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

First Manhattan reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
First Manhattan sold 231,800 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $771K.
First Manhattan first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2017 and held it in 10 quarters.
First Manhattan's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.54M in Q3 2018.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on First Manhattan's 13F filing for Q1 2020, filed 6 May 2020.